Exciting News! BOYDSense Among Top 10 Finalists in Novo Nordisk's "Acteurs du Diabète" Innovation Contest! 🌟 We're thrilled to share that BOYDSense has not only participated but has also emerged as one of the 10 finalists in Novo Nordisk's prestigious "Acteurs du Diabète" innovation contest! 🏆✨ Out of an impressive pool of 36 candidates, Novo Nordisk has recognized BOYDSense's innovative solution for supporting patients in the management of diabetes as among the top 10. This acknowledgement shows our commitment to implement the most innovate technologies to make a positive impact for patients living with diabetes and pre diabetes. We are honored to be recognized as a key player in the quest for solutions that will effectively monitor type II diabetes, by a major global healthcare player. This is a great encouragement to continue our work and achieve our mission. A heartfelt thanks to Novo Nordisk for acknowledging our work. #BOYDSense #Innovation #DiabetesCare #ActeursDuDiabète #NovoNordisk #Top10Finalist 🚀💙
